EWHA, THE FUTURE WE CREATE

EWHA Portal

Ewha W.UEwha W.U

Open Search
Search
Open Mobile Menu

Ewha W.U

Search
nav bar
 
Ewha University

Research News

Distinguished Professor Yoon Juyoung Receives 16th Kyung-Ahm Prize

  • 작성처
  • Date2020.11.13
  • 8219


Distinguished Professor Yoon Juyoung from the Department of Chemistry and Nano Science in the Ewha College of Natural Sciences received an award for the 16th Kyung-Ahm Prize on Friday, November 6.


The Kyung-Ahm Education and Culture Foundation annually selects and awards scholars, experts, and artists who have contributed significantly to the development and advancement of Korean society. This year, the foundation selected a prizewinner each from the four academic fields of the humanities and social sciences, natural sciences, life science, and engineering.


Professor Yoon Juyoung, the prizewinner in the field of natural science, is a leading researcher in Korea who has been selected as a Highly Recited Researcher published by Clarivate Analytics for seven consecutive years from 2014 to 2020. As a world-renowned scholar in the field of organic fluorescent sensors, he has developed a fluorescent sensor that can selectively detect major substances in living organisms such as molecules and ions that are related to degenerative, cardiovascular, and inflammatory diseases. He is currently conducting research on photodynamic therapy, a new concept of cancer treatment based on organic molecules that combines the said sensor system and structures that generate reactive oxygen species in reaction to light.


To date, he has published 385 SCI journals (Hirsch index of 104) and achieved 40 patent registrations and three technology transfers while leading technological research on the theranostics system. Theranostics, a portmanteau of therapy and diagnostics, is a cutting-edge, customizable biomedical model that diagnoses cancer and simultaneously delivers a remedial agent exclusively to the cancer region using substances that target cancer cells. Professor Yoon has laid a groundbreaking framework for the treatment of human diseases through convergence research with researchers in the field of medicine and life sciences as well as a group of computational chemistry experts, thereby pioneering the field of theranostics, which is being increasingly emphasized as a promising future technology.